64
Participants
Start Date
January 31, 2006
Primary Completion Date
June 30, 2007
Study Completion Date
January 31, 2009
Vandetanib (ZD6474)
once daily oral dose
Docetaxel
intravenous infusion
Research Site, Budapest
Research Site, Pécs
Research SIte, Bloemfontein
Research Site, Cape Town
Research Site, Observatory
Research Site, Barakaldo
Research SIte, Lleida
Research Site, Zaragoza
Research Site, Umeå
Research Site, Uppsala
Research Site, Västerås
Research Site, Taipei
Genzyme, a Sanofi Company
INDUSTRY